Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, T-Cell, Cutaneous

Clinical trial condition

Lymphoma, T-Cell, Cutaneous

Explore clinical trials studying Lymphoma, T-Cell, Cutaneous. Study availability and eligibility vary by location and protocol.

387 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Cutaneous trial results

Completed

Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

NCT00317785

Conditions: Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +48 more
Locations: Seattle Cancer Care Alliance Seattle, Washington, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

NCT00010283

Conditions: Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

NCT00003883

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00005804

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

NCT00014391

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +107 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

NCT00005580

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
Locations: New York Presbyterian Hospital - Cornell Campus New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

NCT00043420

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Completed

Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

NCT00211198

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: City of Hope National Medical Center Duarte, California, United States

Yale University School of Medicine New Haven, Connecticut, United States

The University of Iowa Iowa City, Iowa, United States

New England Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

NCT00050999

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States

Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia

Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia

Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia

View all 35 locations

View Trial Details

Completed

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

NCT00051012

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States

Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia

Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia

Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia

View all 34 locations

View Trial Details